Loading…

Lung cancer screening: Current status and perspective

Abstract Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5 mSv, and should be read by radio...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic and interventional imaging 2016-10, Vol.97 (10), p.949-953
Main Authors: Chassagnon, G, Revel, M.-P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3
cites cdi_FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3
container_end_page 953
container_issue 10
container_start_page 949
container_title Diagnostic and interventional imaging
container_volume 97
creator Chassagnon, G
Revel, M.-P
description Abstract Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5 mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.
doi_str_mv 10.1016/j.diii.2016.06.018
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01416745v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211568416301693</els_id><sourcerecordid>1835435108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3</originalsourceid><addsrcrecordid>eNp9kU1rVDEUhoMottT-ARdyl7qYMSffIyKUQa0w4EJdH9LkTM14J3dM7h3ov28uU4u4MBzIITzvu3jC2EvgS-Bg3u6WMaW0FG1f8jbgnrBzIQAW2jj19K_9jF3WuuPtmAYr9ZydCauFFUqeM72Z8m0XfA5UuhoKUU759l23nkqhPHZ19ONUO59jd6BSDxTGdKQX7NnW95UuH-4L9uPTx-_r68Xm6-cv66vNIiilx4UxPoKzwq1sJEsO5DYCN9IIF0PgN1I6Irs1fiXICcUt1yBly2gbLJGXF-zNqfen7_FQ0t6XOxx8wuurDc5vHBQYq_QRGvv6xB7K8HuiOuI-1UB97zMNU0VwUiupgbuGihMaylBroe1jN3Cc7eIOZ7s420XeBubQq4f-6WZP8THyx2UD3p8AakaOiQrWkKiJjak0bRiH9P_-D__EQ59yCr7_RXdUd8NUcnONgFUgx2_z_87fC0a2lpWU9_eSnR0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835435108</pqid></control><display><type>article</type><title>Lung cancer screening: Current status and perspective</title><source>ScienceDirect Journals</source><creator>Chassagnon, G ; Revel, M.-P</creator><creatorcontrib>Chassagnon, G ; Revel, M.-P</creatorcontrib><description>Abstract Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5 mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.</description><identifier>ISSN: 2211-5684</identifier><identifier>EISSN: 2211-5684</identifier><identifier>DOI: 10.1016/j.diii.2016.06.018</identifier><identifier>PMID: 27527243</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Computed tomography ; Cone-Beam Computed Tomography - methods ; Early Detection of Cancer - methods ; Early Detection of Cancer - trends ; False Positive Reactions ; Forecasting ; Human health and pathology ; Humans ; Life Sciences ; Lung ; Lung cancer ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - mortality ; Lung Neoplasms - prevention &amp; control ; Pulmonology and respiratory tract ; Radiation Dosage ; Radiology ; Screening ; Sensitivity and Specificity ; Tomography, X-Ray Computed - methods</subject><ispartof>Diagnostic and interventional imaging, 2016-10, Vol.97 (10), p.949-953</ispartof><rights>Editions françaises de radiologie</rights><rights>2016 Editions françaises de radiologie</rights><rights>Copyright © 2016 Editions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3</citedby><cites>FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27527243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inria.hal.science/hal-01416745$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Chassagnon, G</creatorcontrib><creatorcontrib>Revel, M.-P</creatorcontrib><title>Lung cancer screening: Current status and perspective</title><title>Diagnostic and interventional imaging</title><addtitle>Diagn Interv Imaging</addtitle><description>Abstract Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5 mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.</description><subject>Computed tomography</subject><subject>Cone-Beam Computed Tomography - methods</subject><subject>Early Detection of Cancer - methods</subject><subject>Early Detection of Cancer - trends</subject><subject>False Positive Reactions</subject><subject>Forecasting</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lung</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - prevention &amp; control</subject><subject>Pulmonology and respiratory tract</subject><subject>Radiation Dosage</subject><subject>Radiology</subject><subject>Screening</subject><subject>Sensitivity and Specificity</subject><subject>Tomography, X-Ray Computed - methods</subject><issn>2211-5684</issn><issn>2211-5684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rVDEUhoMottT-ARdyl7qYMSffIyKUQa0w4EJdH9LkTM14J3dM7h3ov28uU4u4MBzIITzvu3jC2EvgS-Bg3u6WMaW0FG1f8jbgnrBzIQAW2jj19K_9jF3WuuPtmAYr9ZydCauFFUqeM72Z8m0XfA5UuhoKUU759l23nkqhPHZ19ONUO59jd6BSDxTGdKQX7NnW95UuH-4L9uPTx-_r68Xm6-cv66vNIiilx4UxPoKzwq1sJEsO5DYCN9IIF0PgN1I6Irs1fiXICcUt1yBly2gbLJGXF-zNqfen7_FQ0t6XOxx8wuurDc5vHBQYq_QRGvv6xB7K8HuiOuI-1UB97zMNU0VwUiupgbuGihMaylBroe1jN3Cc7eIOZ7s420XeBubQq4f-6WZP8THyx2UD3p8AakaOiQrWkKiJjak0bRiH9P_-D__EQ59yCr7_RXdUd8NUcnONgFUgx2_z_87fC0a2lpWU9_eSnR0</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Chassagnon, G</creator><creator>Revel, M.-P</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20161001</creationdate><title>Lung cancer screening: Current status and perspective</title><author>Chassagnon, G ; Revel, M.-P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Computed tomography</topic><topic>Cone-Beam Computed Tomography - methods</topic><topic>Early Detection of Cancer - methods</topic><topic>Early Detection of Cancer - trends</topic><topic>False Positive Reactions</topic><topic>Forecasting</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lung</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - prevention &amp; control</topic><topic>Pulmonology and respiratory tract</topic><topic>Radiation Dosage</topic><topic>Radiology</topic><topic>Screening</topic><topic>Sensitivity and Specificity</topic><topic>Tomography, X-Ray Computed - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chassagnon, G</creatorcontrib><creatorcontrib>Revel, M.-P</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Diagnostic and interventional imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chassagnon, G</au><au>Revel, M.-P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lung cancer screening: Current status and perspective</atitle><jtitle>Diagnostic and interventional imaging</jtitle><addtitle>Diagn Interv Imaging</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>97</volume><issue>10</issue><spage>949</spage><epage>953</epage><pages>949-953</pages><issn>2211-5684</issn><eissn>2211-5684</eissn><abstract>Abstract Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5 mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>27527243</pmid><doi>10.1016/j.diii.2016.06.018</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2211-5684
ispartof Diagnostic and interventional imaging, 2016-10, Vol.97 (10), p.949-953
issn 2211-5684
2211-5684
language eng
recordid cdi_hal_primary_oai_HAL_hal_01416745v1
source ScienceDirect Journals
subjects Computed tomography
Cone-Beam Computed Tomography - methods
Early Detection of Cancer - methods
Early Detection of Cancer - trends
False Positive Reactions
Forecasting
Human health and pathology
Humans
Life Sciences
Lung
Lung cancer
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - mortality
Lung Neoplasms - prevention & control
Pulmonology and respiratory tract
Radiation Dosage
Radiology
Screening
Sensitivity and Specificity
Tomography, X-Ray Computed - methods
title Lung cancer screening: Current status and perspective
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T01%3A14%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lung%20cancer%20screening:%20Current%20status%20and%20perspective&rft.jtitle=Diagnostic%20and%20interventional%20imaging&rft.au=Chassagnon,%20G&rft.date=2016-10-01&rft.volume=97&rft.issue=10&rft.spage=949&rft.epage=953&rft.pages=949-953&rft.issn=2211-5684&rft.eissn=2211-5684&rft_id=info:doi/10.1016/j.diii.2016.06.018&rft_dat=%3Cproquest_hal_p%3E1835435108%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-66ad1872897de7e813fd1063628dcc0b338ee7f6a92e8240705133ad157c7eea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835435108&rft_id=info:pmid/27527243&rfr_iscdi=true